Cost-effectiveness of rituximab (MabThera (R)) in diffuse large B-cell lymphoma in the Netherlands

MT (Martijn) Groot, Elly Lugtenburg, J Hornberger, PC Huijgens, Carin Uyl - de Groot

Research output: Contribution to journal › Article › Academic › peer-review

41 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	194-202
Number of pages	9
Journal	European Journal of Haematology
Volume	74
Issue number	3
DOIs	https://doi.org/10.1111/j.1600-0609.2004.00368.x
Publication status	Published - 2005

Access to Document

@article{b4148865b26449c4877f2438e7d8ebed,

title = "Cost-effectiveness of rituximab (MabThera (R)) in diffuse large B-cell lymphoma in the Netherlands",

author = "Groot, {MT (Martijn)} and Elly Lugtenburg and J Hornberger and PC Huijgens and {Uyl - de Groot}, Carin",

year = "2005",

doi = "10.1111/j.1600-0609.2004.00368.x",

language = "Undefined/Unknown",

volume = "74",

pages = "194--202",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Cost-effectiveness of rituximab (MabThera (R)) in diffuse large B-cell lymphoma in the Netherlands

AU - Groot, MT (Martijn)

AU - Lugtenburg, Elly

AU - Hornberger, J

AU - Huijgens, PC

AU - Uyl - de Groot, Carin

PY - 2005

Y1 - 2005

U2 - 10.1111/j.1600-0609.2004.00368.x

DO - 10.1111/j.1600-0609.2004.00368.x

M3 - Article

SN - 0902-4441

VL - 74

SP - 194

EP - 202

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 3

ER -